NDC properties for NDC 9 49502-417
NDC item 49502041702
NDC 9 | 49502-417 |
---|---|
NDC 10 | 49502-417-02 |
NDC Item | 49502041702 |
packaging | 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET |
BLA | BLA761154 |
FDA SPL set id | 860490 |
Labeler | Viatris Specialty LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2023-07-02 |
Marketing status | ACTIVE |
NDC item 49502041706
NDC 9 | 49502-417 |
---|---|
NDC 10 | 49502-417-06 |
NDC Item | 49502041706 |
BLA | BLA761154 |
FDA SPL set id | 860490 |
Labeler | Viatris Specialty LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time high | 2025-10-31 |
Marketing effective time low | 2023-07-02 |
Marketing status | ACTIVE |
NDC item 83257002042
NDC 9 | 83257-020 |
---|---|
NDC 10 | 83257-020-42 |
NDC Item | 83257002042 |
packaging | 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
BLA | BLA761154 |
FDA SPL set id | 788036 |
Labeler | Biocon Biologics Inc |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-04-15 |
Marketing status | ACTIVE |